STUDIES OF TOPOISOMERASE-SPECIFIC ANTITUMOR DRUGS IN HUMAN-LYMPHOCYTES USING RABBIT ANTISERA AGAINST RECOMBINANT HUMAN TOPOISOMERASE-II POLYPEPTIDE

被引：0
|
作者：
HWANG, JL [1 ]
SHYY, SH [1 ]
CHEN, AY [1 ]
JUAN, CC [1 ]
WHANGPENG, J [1 ]
机构：
[1] NCI, DIV CANC TREATMENT, MED BRANCH, BETHESDA, MD 20892 USA
来源：
CANCER RESEARCH | 1989年 / 49卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：958 / 962
页数：5
相关论文
共 50 条
  • [21] RESISTANCE OF HUMAN-LEUKEMIC AND NORMAL LYMPHOCYTES TO DRUG-INDUCED DNA CLEAVAGE AND LOW-LEVELS OF DNA TOPOISOMERASE-II
    POTMESIL, M
    HSIANG, YH
    LIU, LF
    BANK, B
    GROSSBERG, H
    KIRSCHENBAUM, S
    FORLENZAR, TJ
    PENZINER, A
    KANGANIS, D
    KNOWLES, D
    TRAGANOS, F
    SILBER, R
    CANCER RESEARCH, 1988, 48 (12) : 3537 - 3543
  • [22] In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts
    Gilles Vassal
    Jean-Louis Merlin
    Marie-José Terrier-Lacombe
    Jacques Grill
    Fabrice Parker
    Christian Sainte-Rose
    Geneviève Aubert
    Jackie Morizet
    Nicolas Sévenet
    Marie-Gwenaëlle Poullain
    Catherine Lucas
    Chantal Kalifa
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 385 - 394
  • [23] In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts
    Vassal, G
    Merlin, JL
    Terrier-Lacombe, MJ
    Grill, J
    Parker, F
    Sainte-Rose, C
    Aubert, G
    Morizet, J
    Sévenet, N
    Poullain, MG
    Lucas, C
    Kalifa, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (05) : 385 - 394
  • [24] RECONSTITUTION OF TOPOISOMERASE II-MEDIATED DRUG SENSITIVITY IN SOMATIC-CELL HYBRIDS OF RESISTANT CHO CELLS AND NORMAL HUMAN-LYMPHOCYTES
    GLISSON, BS
    ROSS, WE
    WOODWARD, J
    SICILIANO, MJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 501 - 501
  • [25] AN ANTIBODY AGAINST A SEQUENCE OF HUMAN TOPOISOMERASE-II GIVES DIFFERENT IMMUNOFLUORESCENCE PATTERNS IN QUIESCENT AND PROLIFERATING NUCLEI OF PISUM-SATIVUM L
    LEVI, M
    SPARVOLI, E
    CORBETTA, N
    JOURNAL OF EXPERIMENTAL BOTANY, 1994, 45 (277) : 1157 - 1162
  • [26] 2 SPECIFIC TOPOISOMERASE-II INHIBITORS PREVENT REPLICATION OF HUMAN CYTOMEGALO-VIRUS DNA - AN IMPLIED ROLE IN REPLICATION OF THE VIRAL GENOME
    BENSON, JD
    HUANG, ES
    JOURNAL OF VIROLOGY, 1988, 62 (12) : 4797 - 4800
  • [27] ANTITUMOR AGENTS .100. INHIBITION OF HUMAN DNA TOPOISOMERASE-II BY CYTO-TOXIC ETHER AND ESTER DERIVATIVES OF PODOPHYLLOTOXIN AND ALPHA-PELTATIN
    THURSTON, LS
    IMAKURA, Y
    HARUNA, M
    LI, DH
    LIU, ZC
    LIU, SY
    CHENG, YC
    LEE, KH
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) : 604 - 608
  • [28] ANTITUMOR AGENTS .144. NEW GAMMA-LACTONE RING-MODIFIED ARYLAMINO ETOPOSIDE ANALOGS AS INHIBITORS OF HUMAN DNA TOPOISOMERASE-II
    ZHOU, XM
    LEE, KJH
    CHENG, J
    WU, SS
    CHEN, HX
    GUO, X
    CHENG, YC
    LEE, KH
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) : 287 - 292
  • [29] THE ENHANCED ANTITUMOR-ACTIVITY OF DNA TOPOISOMERASE II-TRAPPING DRUGS BY NATURAL HUMAN TUMOR-NECROSIS-FACTOR AGAINST HUMAN GLIOMA CELL-LINES IN-VITRO
    KAMIKASEDA, K
    STAVROU, D
    FUKUI, M
    ONCOLOGY REPORTS, 1994, 1 (04) : 735 - 738
  • [30] HT1080/DR4 - A P-GLYCOPROTEIN-NEGATIVE HUMAN FIBROSARCOMA CELL-LINE EXHIBITING RESISTANCE TO TOPOISOMERASE-II-REACTIVE DRUGS DESPITE THE PRESENCE OF A DRUG-SENSITIVE TOPOISOMERASE-II
    ZWELLING, LA
    SLOVAK, ML
    DOROSHOW, JH
    HINDS, M
    CHAN, D
    PARKER, E
    MAYES, J
    SIE, KL
    MELTZER, PS
    TRENT, JM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) : 1553 - 1561
12345